Gene · 10219
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vaccine development against tuberculosis before and after Covid-19. | Front Immunol | 2023 | 38035095 | PubTator, text mining | PubMed |
| Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer. | Cancer Res Commun | 2023 | 38032111 | PubTator, text mining | PubMed |
| PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. | Nat Commun | 2023 | 38030622 | PubTator, text mining | PubMed |
| Understanding latent HIV-1 reservoirs through host genomics approaches. | iScience | 2023 | 38026212 | PubTator, text mining | PubMed |
| Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment. | Front Oncol | 2023 | 38023191 | PubTator, text mining | PubMed |
| NK cell exhaustion in the tumor microenvironment. | Front Immunol | 2023 | 38022646 | PubTator, text mining | PubMed |
| Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. | Sci Adv | 2023 | 38019919 | PubTator, text mining | PubMed |
| Immunosenescence and cancer: Opportunities and challenges. | Medicine (Baltimore) | 2023 | 38013358 | PubTator, text mining | PubMed |
| CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies. | Nat Commun | 2023 | 38012187 | PubTator, text mining | PubMed |
| Characteristics of circulating immune cells in HBV-related acute-on-chronic liver failure following artificial liver treatment. | BMC Immunol | 2023 | 38007423 | PubTator, text mining | PubMed |
| PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review. | Viruses | 2023 | 38005875 | PubTator, text mining | PubMed |
| The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria. | NPJ Vaccines | 2023 | 37996533 | PubTator, text mining | PubMed |
| The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome. | Nat Commun | 2023 | 37996443 | PubTator, text mining | PubMed |
| Animal models of primary biliary cholangitis: status and challenges. | Cell Biosci | 2023 | 37993960 | PubTator, text mining | PubMed |
| Bony-fish-like scales in a Silurian maxillate placoderm. | Nat Commun | 2023 | 37993457 | PubTator, text mining | PubMed |
| Coordinated immune dysregulation in Juvenile Dermatomyositis revealed by single-cell genomics. | bioRxiv | 2023 | 37986917 | PubTator, text mining | PubMed |
| Early-to-mid stage idiopathic Parkinson's disease shows enhanced cytotoxicity and differentiation in CD8 T-cells in females. | Nat Commun | 2023 | 37985656 | PubTator, text mining | PubMed |
| Longitudinal multi-functional analysis identified responses of T cells, B cells, and monocytes as hallmarks of immunotherapy tolerance in patients with merkel cell carcinoma. | PLoS One | 2023 | 37983224 | PubTator, text mining | PubMed |
| Abundant binary promoter switches in lineage-determining transcription factors indicate a digital component of cell fate determination. | Cell Rep | 2023 | 37976160 | PubTator, text mining | PubMed |
| Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells. | PLoS Pathog | 2023 | 37972198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10219/papers?page=14